Steve Allen intends to retire as chairman and a director of ChromaDex Corp.
Allen, who is stepping down after four years of service, will not stand for re-election as a director at the company's annual meeting in June.
ChromaDex chairman to retire
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Steve Allen intends to retire as chairman and a director of ChromaDex Corp.
Allen, who is stepping down after four years of service, will not stand for re-election as a director at the company's annual meeting in June.